Search PubMed⌕ Search

Biomedical subjects

M Muranaka

Publications and source records attributed to M Muranaka.

At least 55 records · Page 3Linked to original sources
PubMed1981

Bronchial responsiveness to acetylcholine in patients with bronchial asthma after long-term treatment with gold salt.

Three groups of adult patients with bronchial asthma were subjected to long-term chrysotherapy (gold therapy), immunotherapy, or symptomatic therapy. Five of 14 patients who were treated with repeated injections of gold salt entered a symptom-free state that continued for more than 3 yr without the use of any bronchodilators or corticosteroids. In the other groups, there were no patients who entered such a state of long-term remission during the treatment. A statistically significant decrease in the bronchial responsiveness to inhaled acetylcholine was also observed in patients who received chrysotherapy. In the other groups, there were no significant differences between the bronchial responsiveness to acetylcholine that was estimated before the treatment and that measured after long-term treatment. Long-term chrysotherapy in the asthmatic patients did not reduce their serum level of total IgE. Gold salt, which is generally accepted as an antirheumatic drug, has also been used as an antiasthmatic drug by some Japanese practitioners despite the absence of evidence to support the therapeutic effect of the drug on asthma; the results of the study provide more information on the treatment of bronchial asthma with gold therapy.

Acetylcholine↗
PubMed1980

Clinical evaluation of a new orally active anti-anaphylactic compound: ketotifen (HC 20-511) in Japanese adult asthmatics.

The protective effect of ketotifen was examined by an open assessment trial in 261 asthmatics of variable types, a double blind trial comparing ketotifen and inert placebo in 189 asthmatics of extrinsic type including pure atopic asthma and asthma with atopic and infectious components (mixed type or combined type), and a double blind trial comparing ketotifen and disodium cromoglycate (DSCG) by double placebo technique in 132 asthmatics of a pure atopic type. The open clinical assessment trial suggested that ketotifen was most effective in atopic asthmatics having moderate and severe as well as mild asthmatic episodes. Efficacy increased with prolonged administration; 1 mg twice daily was better than a 1 mg daily dose. In the placebo-controlled double blind trial, the efficacy of ketotifen was demonstrated by the reduction of concomitant anti-asthmatic therapy. The results of the double blind trial comparing ketotifen and DSCG are not fully reported. However, preliminary data showed that the efficacy of both drugs was equivalent or that ketotifen was slightly superior to DSCG. Safety of ketotifen was confirmed by the three trials, transient day-time sedation being the major side effect of this agent. In conclusion, ketotifen is a promising drug for the prophylaxis of asthma.

Adult↗
PubMed1980

Antigenicity of semisynthetic penicillin preparations to evoke systemic anaphylactic reactions in animal models.

Four commercially available penicillin preparations (benzylpenicillin, aminobenzylpenicillin, carbenicillin and sulbenicillin) and two kinds of the new semisynthetic penicillin preparations (mezlocillin and piperacillin) evoked systemic anaphylactic reactions in guinea pigs immunized with one of the following penicillin-Ascaris extract (As) conjugates in aluminum hydroxide gel (alum), i.e., benzylpenicilloyl (BPO)-As, aminobenzylpenicilloyl (ABPO)-As, carbenicilloyl (CBPO)-As, sulbenicilloyl (SBPO)-As, mezlocillin-As conjugate (MEZ-As) and piperacillin-As conjugate (PIP-As). The tracheal chains prepared from the tracheas of the guinea pigs immunized with BPO-As, MEZ-As, or PIP-As revealed anaphylactic contractions in vitro on addition of benzylpenicillin, mezlocillin, or piperacillin preparations. These results indicated that the semisynthetic penicillin preparations as well as benzylpenicillin preparation have enough antigenicity to evoke systemic anaphylactic reactions in guinea pigs immunized with penicillin-As conjugate. Such guinea pigs seem to be suitable animals for investigations of penicillin allergy.

Allergens↗
PubMed1980

IgE antibodies produced in mice instrumental in analyses of antigenicity of cephalothin preparation.

IgE antibodies to a cephalothin preparation were produced in mice which had been immunized with cephalothin-Ascaris extract conjugate mixed with Al(OH)3 gel plus Bordetella pertussis. Mice which had been irradiated just before receiving the booster injection wtih the conjugate showed higher IgE antibody levels against the preparation in comparison with unirradiated mice. The specificities of IgE antibodies against the preparation were examined with an inhibition test of passive cutaneous anaphylactic (PCA) reaction. The intensity of the PCA reaction evoked by the cephalothin preparation in the rats was substantially or partially reduced by a pretreatment of the animals with an injection of a cephalothin preparation from another source or a cephaloridine preparation. Meanwhile, a prior injection of a cefazolin, a 7-aminocephalosporanic acid, a benzylpenicillin (PcG) preparation, or an aminobenzylpenicillin preparation into the animals showed only weak or no influence on the PCA reaction. These results suggest that the acyl side chain of cephalothin plays an important role as eliciting antigenic determinant in the PCA reaction. The difference in the antigenic specificity between the cephalothin and PcG preparation is also discussed.

Animals↗
PubMed1978

Benzylpenicillin preparations can evoke a systemic anaphylactic reaction in guinea pigs.

All of the five commercially available benzylpenicillin preparations obtained from different sources and a PcG preparation prepared by filtration of a commercial PcG on Sephadex G10 elicited the systemic anaphylactic reactions in guinea pigs which had been immunized with benzylpenicilloyl (BPO)-Ascaris extract conjugate (BPO-As) mixed with aluminum bydroxide gel. These preparations could evoke no such reactions in guinea pigs immunized with BPO-bovine gamma globulin conjugate (BPO-BGG) emulsified with complete Freund's adjuvant. The severity of the systemic anaphylactic reactions correlated significantly with the titers of either 8-day passive cutaneous anaphylactic (8-day PCA) reactions or 4-hr PCA reactions evoked with the same benzylpenicillin preparations. In vitro benzylpenicillin preparation contracted the tracheas of the guinea pigs immunized with BPO-As. These results indicated that the commercially available benzylpenicillin preparations have enough antigenicity to evoke systemic anaphylactic reactions in guinea pigs immunized with BPO-As mixed with aluminum hydroxide gel. Such guinea pigs represent an animal model for investigation of penicillin allergy.

Anaphylaxis↗
PubMed1978

Gold salt in the treatment of bronchial asthma--a double-blind study.

The efficacy of gold salt on bronchial asthma was investigated by double-blind design in 79 patients. The rate of improvement was significantly higher in the gold-treated group (20/28) than in the controls (16/36). This was reflected by greater reduction of requirement for symptomatic medications. Only mild side effects were observed in 14 patients out of 38 gold-treated patients.

Asthma↗